Summit Partners Public Asset Management, Llc
Source: SEC Form 13F · as of Mar 2026Summit Partners Public Asset Management, Llc holds 7 biotech & pharma companies tracked by BioSniper, totaling $464.7M in value as of Mar 2026 (SEC Form 13F).
Companies held
7
Total value held
$464.7M
BioSniper AIPage evidence connected
Prepared research question
What matters most for IONIS PHARMACEUTICALS INC (IONS)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| IONSIONIS PHARMACEUTICALS INC | 1,854,033 | $139.2M |
| GHGuardant Health Inc. | 1,212,915 | $112.0M |
| INSMINSMED Inc | 653,445 | $106.9M |
| ARWRARROWHEAD PHARMACEUTICALS, INC. | 690,144 | $43.3M |
| BBIOBridgeBio Pharma, Inc. | 502,831 | $37.3M |
| CSTLCastle Biosciences Inc. | 940,685 | $23.1M |
| KMTSKestra Medical Technologies Ltd. | 147,273 | $2.9M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.